Related Experiment Video
Updated: Jul 12, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Experiences and Predictors of Real-Time Prescription Drug Monitoring Program Use Among Australian Community
Louisa Picco1, Monica Jung1, Rose Laing1
1Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
Introduction:
Prescription drug monitoring programs (PDMP) are a key supply-side policy aimed at reducing medication-related harms, which have been implemented in all Australian states and territories; however, experiences have not been explored nationally among community pharmacists. The objectives of this study were to investigate PDMP use among Australian community pharmacists, including frequency of use, reasons for and barriers to use.
Methods:
An anonymous online survey collected data on: (i) the pharmacist (i.e., gender, years of pharmacy experience, PDMP training) and the pharmacy (i.e., location, pharmacy type, average number of daily prescriptions received); and (ii) PDMP use (i.e., frequency of use, reasons for checking PDMP, frequency of barriers experienced). Logistic regression was used to explore the factors associated with frequent PDMP use.
Results:
Among a sample of 730 community pharmacists, regular ('all the time') PDMP use was more common in mandated (74.1%), compared to non-mandated (45.7%) states/territories (p < 0.001). Few pharmacists reported experiencing barriers 'all the time' in mandated (4.0%) and non-mandated (4.8%) states/territories. Pharmacists working in mandated states/territories (aOR: 3.64; 95% CI 2.60-5.09), capital cities (aOR: 1.90; 95% CI 1.34-2.70) and pharmacies that are part of chain/banner group (aOR: 1.49; 95% CI 1.04-2.13) were more likely to use PDMP 'all the time', compared with those with less frequent use.
Discussion And Conclusions:
Australian community pharmacists demonstrate variations in the frequency and reasons for PDMP use. Concerted efforts through education and practise-level interventions are needed to encourage PDMP use, particularly in non-mandated states and territories, independent pharmacies, and those working outside capital cities.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Drug Analysis Methods
Pharmaceutical Poisoning: Potential Scenarios
Dosage Regimens: Partial Pharmacokinetic Parameters
Analysis of Population Pharmacokinetic Data

